Skip to content
User

Eric H. Schoenstein

Jensen Investment Management

Eric H. Schoenstein Merck & Company Inc stake

total: 257

Jensen Investment Management MRK trades

Total transactions:
7
New positions:
3
Sold out:
3
Reduced:
1
Held since:
2016 Q1
Held for:
2 quarters
Latest activity:
2016 Q3
According to 2026 Q2 report, Eric H. Schoenstein doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $52.93 for "buy" trades and estimated average "sell" price is $57.67. Jensen Investment Management first purchased MRK in 2015 Q1, initially acquiring 9,530 shares. Eric H. Schoenstein later completely sold out the position and invested in Merck & Company Inc again in 2016 Q1. Since the initial investment in Merck & Company Inc (MRK), Jensen Investment Management has made 6 more transactions.

When did Eric H. Schoenstein sell Merck & Company Inc (MRK)?

Eric H. Schoenstein sold off the entire Merck & Company Inc (MRK) position in 2016 Q3.

When did Eric H. Schoenstein buy Merck & Company Inc (MRK)?

Eric H. Schoenstein first invested in Merck & Company Inc (MRK) in 2015 Q1 at the reported quarter-end price of $57.50 per share.

What's the cost basis of Jensen Investment Management's MRK stake?

The estimated cost basis for Merck & Company Inc (MRK) stake is around $52.93 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$52.93
Weighted AVG sell price:
$57.67

Eric H. Schoenstein's historical trades in Merck & Company Inc

7 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2016 Q3
0.00%
$57.67
-100% (-7,560)
2016 Q2
0.01%
$57.67
-3.82% (-300)
2016 Q1
0.01%
$52.93
new
2015 Q4
0.00%
$49.39
-100% (-7,370)
2015 Q3
0.01%
$49.39
new
2015 Q2
0.00%
$57.50
-100% (-9,530)
2015 Q1
0.01%
$57.50
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.